Viewing Study NCT01476332


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-01-13 @ 12:41 AM
Study NCT ID: NCT01476332
Status: COMPLETED
Last Update Posted: 2012-05-17
First Post: 2011-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
Sponsor: Laurantis Pharma, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module